Further investigation indicated that d-ICD diminished the CD133+ CSC subpopulation in HCC and downregulated ABCB1, ABCG2 and CD133 expression via IGF2BP3 suppression. The gene discussed is ABCB1; the disease is hepatocellular carcinoma.